Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
11/30/2006 | US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
11/30/2006 | US20060270002 Factor VII or VIIa Polypeptide Variants |
11/30/2006 | US20060270001 Factor VII or VIIa Polypeptide Variants |
11/30/2006 | US20060270000 Factor VII or VIIa Polypeptide Variants |
11/30/2006 | US20060269954 Self-assembling recombinant papillomavirus capsid proteins |
11/30/2006 | US20060269632 Remedies for allergic diseases and process for producing the same |
11/30/2006 | US20060269627 Isolation of a Dual Cox-2 and 5-Lipoxygenase Inhibitor from Acacia |
11/30/2006 | US20060269625 Methods of inhibiting proliferation of cells |
11/30/2006 | US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis |
11/30/2006 | US20060269548 Lymphatic endothelial cells materials and methods |
11/30/2006 | US20060269504 Use of alkyl resorcinols in the treatment of acne |
11/30/2006 | DE202006014985U1 Composition, useful for improving skin- and bone condition, comprises fat oils from seeds of black nettle (Perilla frutescens), vitamin C, vitamin E, calcium, vitamin K1 and vitamin D3 |
11/30/2006 | DE102005023666A1 Use of marmot oils for the treatment of skin diseases such as acne vulgaris, acne rosacea, neurodermitits, phlebitis, herpes or external hemorrhoids |
11/30/2006 | CA2608220A1 Methods and compositions using 4[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperridin-3yl) isoindole-1,3-dione for the treatment of prevention of cutaneous lupus |
11/29/2006 | EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1 |
11/29/2006 | EP1725248A1 Preparations containing echinacea extracts and thiocyanate |
11/29/2006 | EP1725245A2 Manganese and iron based compounds for elastogenesis and connective tissue treatment |
11/29/2006 | EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
11/29/2006 | EP1478381A4 Use of soluble gamma delta t cell receptors for regulating t cell function |
11/29/2006 | EP1397124B1 Use of antidiabetics for making a medicine with cicatrizing effect |
11/29/2006 | EP1146866B1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor |
11/29/2006 | EP1024792B1 Topical antifungal composition |
11/29/2006 | CN1871240A Pyrrolopyrimidine thion derivatives |
11/29/2006 | CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
11/29/2006 | CN1871006A Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants |
11/29/2006 | CN1870971A Cosmetic composition comprising extract from mallotus japonicus for improving skin wrinkle |
11/29/2006 | CN1869238A Biological agent for repairing ulcer |
11/29/2006 | CN1869080A Novel inverse latices of copolymers of amps and of n,n-dimethylacrylamide; cosmetic use |
11/29/2006 | CN1869071A Recombination immune therapeutic protein and its expression method and application |
11/29/2006 | CN1868544A Amino-acid modified chitin nucleophic NO donor and its synthesis method |
11/29/2006 | CN1868526A Soft capsule of active rhizoma gastrodiae, and its prepn. method |
11/29/2006 | CN1868514A Traditional Chinese medicine capsule for treating leucoderma, and its prepn. method |
11/29/2006 | CN1868505A 蛇胆粉胶囊 Snake Powder Capsules |
11/29/2006 | CN1868494A Vinegar with function of treating barbier |
11/29/2006 | CN1868450A Cream contg. doxepin hydrochloride, and its prepn. method |
11/29/2006 | CN1868420A Human soft tissue filler for injection, and its prepn. method |
11/29/2006 | CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
11/29/2006 | CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
11/29/2006 | CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound |
11/29/2006 | CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy |
11/29/2006 | CN1286529C Skin targeting medicinal composition and its preparation and use |
11/29/2006 | CN1286513C Chinese medicine composition for treating dermatosis and its preparing method |
11/29/2006 | CN1286505C Prepared Chinese medicine for treating various kinds of face spots |
11/29/2006 | CN1286497C Plaster for treating shank sore |
11/29/2006 | CN1286489C Scarless burn and scald treatment liquid and its preparation method |
11/29/2006 | CN1286470C Medicine for treating acne and preparation method thereof |
11/29/2006 | CN1286469C Pharmaceutical use of isolarisiresinol |
11/29/2006 | CN1286459C Transparent and disappearing external medicine preparation containing benzotolazo |
11/29/2006 | CN1286457C Freeze-dried powder injection of andrographolide and preparation thereof |
11/29/2006 | CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural |
11/28/2006 | US7141674 Anti-inflammatory compounds |
11/28/2006 | US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
11/28/2006 | US7141580 activity as prostaglandin E2 receptor antagonists |
11/28/2006 | US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS |
11/28/2006 | US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
11/28/2006 | US7141363 Purposeful movement of human migratory cells away from an agent source |
11/28/2006 | US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
11/28/2006 | US7141237 Pharmaceutical foam |
11/28/2006 | CA2379786C Purine derivatives |
11/28/2006 | CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
11/28/2006 | CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
11/28/2006 | CA2222311C Use of at least one beta-adrenergic agonist as a p substance antagonist |
11/28/2006 | CA2200409C Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
11/28/2006 | CA2137203C Protein kinase c inhibitors |
11/23/2006 | WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
11/23/2006 | WO2006123726A1 Pharmaceutical composition |
11/23/2006 | WO2006123724A1 Novel pharmaceutical using anti-hla antibody |
11/23/2006 | WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
11/23/2006 | WO2006123639A1 Pyrimidine derivative |
11/23/2006 | WO2006123618A1 Oxidative stress inhibitor |
11/23/2006 | WO2006123226A2 An inhibitor of mtor for inhibiting the formation of scar tissue |
11/23/2006 | WO2006122883A1 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne |
11/23/2006 | WO2006122685A1 Compositions for the treatment of psoriasis |
11/23/2006 | WO2006122668A1 Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine |
11/23/2006 | WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses |
11/23/2006 | WO2006106164B1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles |
11/23/2006 | WO2006103056A3 Topical product containing betaine for preventing and treating nappy rash |
11/23/2006 | WO2006084015A3 Raf inhibitor compounds and methods |
11/23/2006 | WO2006040688B1 Inhibitors of acetylcholinesterase for treating skin diseases |
11/23/2006 | US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis |
11/23/2006 | US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors |
11/23/2006 | US20060264464 Amidino compounds as cysteine protease inhibitors |
11/23/2006 | US20060264456 Phosphorus-containing compounds & uses thereof |
11/23/2006 | US20060264434 Chemokine receptor binding heterocyclic compounds |
11/23/2006 | US20060263881 Methods of expanding and selecting disease associated T-Cells |
11/23/2006 | US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
11/23/2006 | US20060263422 Pharmaceutical composition containing decoy and use of the same |
11/23/2006 | DE102006019794A1 Use of glycerylglycosides for stimulating aquaporin expression and in the preparation of cosmetics |
11/23/2006 | DE102005023640A1 Active substance combination, useful for skin moisturizing and stabilization of skin barrier, comprises glucosylglycerides and partially neutralized esters of monoglyceride and/or diglyceride fatty acids with citronic acids |
11/23/2006 | DE102005023639A1 Active substance combination, useful for skin moisturizing and for stabilizing skin barrier, comprises glucosylglycerides, boundary surface-active glucose derivatives and boundary surface-active oligoglycerine derivatives |
11/23/2006 | DE102005023636A1 Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin Active compound combinations of glucosyl glycerides and creatine and / or creatinine |
11/23/2006 | DE102005022845A1 Thiobernsteinsäurederivate und deren Verwendung Thiobernsteinsäurederivate and their use |
11/23/2006 | DE102005022625A1 Verwendung von Taurin zur Steigerung der epidermalen Lipidsynthese Use of taurine to increase epidermal lipid synthesis |
11/23/2006 | CA2609102A1 Int6 protein involved in hypoxia stress induction and use thereof |
11/23/2006 | CA2608447A1 Oxidative stress inhibitor |
11/23/2006 | CA2608383A1 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form |
11/23/2006 | CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
11/23/2006 | CA2606567A1 Use of adamantyl methoxydiphenyl propenoic acid for the treatment of acne |
11/22/2006 | EP1724349A1 TIE Ligand Homologues |
11/22/2006 | EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |